New inhibitory signaling by CTLA-4

被引:0
|
作者
Christoph Wülfing
Helen M Tunbridge
David C Wraith
机构
[1] Christoph Wülfing,
[2] Helen M. Tunbridge and David C. Wraith are with the School of Cellular and Molecular Medicine,undefined
[3] University of Bristol,undefined
[4] Bristol,undefined
[5] UK.,undefined
来源
Nature Immunology | 2014年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
CTLA-4 is a potent inhibitor of T cell population expansion. The PIX-GIT2-PAK2 complex is recruited to the cytoplasmic domain of CTLA-4 via the kinase PKC-η, which suggests a previously unrecognized aspect of signal transduction via CTLA-4 in immunoregulation.
引用
收藏
页码:408 / 409
页数:1
相关论文
共 50 条
  • [31] Therapeutic options for CTLA-4 insufficiency
    Egg, David
    Rump, Ina Caroline
    Mitsuiki, Noriko
    Rojas-Restrepo, Jessica
    Maccari, Maria-Elena
    Schwab, Charlotte
    Gabrysch, Annemarie
    Warnatz, Klaus
    Goldacker, Sigune
    Patino, Virginia
    Wolff, Daniel
    Okada, Satoshi
    Hayakawa, Seiichi
    Shikama, Yoshiaki
    Kanda, Kenji
    Imai, Kohsuke
    Sotomatsu, Manabu
    Kuwashima, Makoto
    Kamiya, Takahiro
    Morio, Tomohiro
    Matsumoto, Kazuaki
    Mori, Takeshi
    Yoshimoto, Yuri
    Dybedal, Ingunn
    Kanariou, Maria
    Kucuk, Zeynep Yesim
    Chapdelaine, Hugo
    Petruzelkova, Lenka
    Lorenz, Hanns-Martin
    Sullivan, Kathleen E.
    Heimall, Jennifer
    Moutschen, Michel
    Litzman, Jiri
    Recher, Mike
    Albert, Michael H.
    Hauck, Fabian
    Seneviratne, Suranjith
    Schmid, Jana Pachlopnik
    Kolios, Antonios
    Unglik, Gary
    Klemann, Christian
    Snapper, Scott
    Giulino-Roth, Lisa
    Svaton, Michael
    Platt, Craig D.
    Hambleton, Sophie
    Neth, Olaf
    Gosse, Geraldine
    Reinsch, Steffen
    Holzinger, Dirk
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : 736 - 746
  • [32] CTLA-4 upregulation during aging
    Leng, QB
    Bentwich, Z
    Borkow, G
    MECHANISMS OF AGEING AND DEVELOPMENT, 2002, 123 (10) : 1419 - 1421
  • [33] CTLA-4 blockade: Autoimmunity as treatment
    Kapadia, D
    Fong, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) : 8926 - 8928
  • [34] A molecular perspective of CTLA-4 function
    Teft, Wendy A.
    Kirchhof, Mark G.
    Madrenas, Joaquin
    ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 65 - 97
  • [35] The role of CTLA-4 in Treg function
    Qureshi, O. S.
    Zheng, Y.
    Manzotti, C. N.
    Walker, L. S. K.
    Sansom, D. M.
    IMMUNOLOGY, 2008, 125 : 64 - 64
  • [36] CTLA-4: a key protein in autoimmunity
    Jagadeesh Bayry
    Nature Reviews Rheumatology, 2009, 5 : 244 - 245
  • [37] CTLA-4: a key protein in autoimmunity
    Bayry, Jagadeesh
    NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (05) : 244 - 245
  • [38] Molecular and Cellular Functions of CTLA-4
    Van Coillie, Samya
    Wiernicki, Bartosz
    Xu, Jie
    REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY, 2020, 1248 : 7 - 32
  • [39] Regulation of systemic autoimmunity by CTLA-4
    Chuang, E
    Zhou, L
    Yi, A
    Elkon, K
    FASEB JOURNAL, 2001, 15 (04): : A343 - A343
  • [40] Expression of CTLA-4 by human monocytes
    Wang, XB
    Giscombe, R
    Yan, Z
    Heiden, T
    Xu, D
    Lefvert, AK
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (01) : 53 - 60